EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity

Husam Nawafleh iD, Nagwa Zeinelabdin iD, Michelle K Greene, Anitha Krishnan, Linus Ho, Mohamed Genead, Derek Kunimoto, Christopher J Scott, Michael Tolentino iD, Salem Chouaib

Pharmaceuticals · 28.10.2024 · 17 (11) · 1443

DOI: 10.3390/ph17111443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 28.10.2024. Verfasst von Husam Nawafleh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aviceda Therapeutics, Gulf Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Tumor microenvironmental hypoxia is an established hallmark of solid tumors. It significantly contributes to tumor aggressiveness and therapy resistance and has been reported to affect the balance of activating/inhibitory surface receptors’ expression and activity on NK cells. In the current study, we investigated the impact of hypoxia on the surface expression of Siglec-7 and Siglec-9 (Sig-7/9) and their ligands in NK cells and tumor target cells. The functional consequence of Siglec blockage using nanoparticles specifically designed to target and block Sig-7/9 receptors on NK cell cytotoxicity was elucidated.

Methods

CD56⁺ CD3− NK cells were isolated from PBMCs along with an NK-92 clone and used as effector cells, while MCF-7 and K562 served as target cells. All cells were incubated under normoxic or hypoxic conditions for 24 h. To assess Siglec-7 and Siglec-9 receptor expression, U937, NK-92, and primary NK cells were stained with PE-labeled antibodies against CD328 Siglec-7/9. Interactions between Siglec-7/9 and their sialylated ligands, along with their functional impact on NK cell activity, were evaluated using polymeric nanoparticles coated with a sialic acid mimetic. Immunological synapse formation and live-cell imaging were performed with a ZEISS LSM 800 with Airyscan at 10× magnification for 24 h.

Results

Our data indicate that hypoxia had no effect on the expression of Siglec-7/9 receptors by NK cells. In contrast, hypoxic stress resulted in an increase in Siglec-7 sialoglycan ligand expression by a sub-population of NK target cells. Using polymeric nanoparticles coated with a sialic acid mimetic that binds both Siglec-7 and -9 (Sig-7/9 NP), we demonstrated that incubation of these nanoparticles with NK cells resulted in increased immunological synapse formation, granzyme B accumulation, and killing of NK target cells. These studies indicate that hypoxic stress may have an impact on NK cell-based therapies and highlight the need to consider the hypoxic microenvironment for tumor-specific glycosylation.

Conclusions

Our findings point to the role of Siglec–sialylated glycan interactions in hypoxic stress-induced NK cell dysfunction and recommend the potential integration of the manipulation of this axis through the targeting of Siglecs in future cancer immunotherapy strategies.

Schlagwörter

Stichwörter der Autor:innen

NK cellshypoxiaimmune synapsesnanoparticlessialoglycan ligandssiglec receptors

Autor:innen und Institutionen

  • Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman 4184, United Arab Emirates.
  • Aviceda Glycotech, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Aviceda Therapeutics Inc., Cambridge, MA 02142, USA.
  • Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT7 1NN, UK.

ORCID-Profile: Husam Nawafleh, Nagwa Zeinelabdin, Michael Tolentino

Förderung

  • Aviceda Therapeutics
  • Gulf Medical University

Zitieren

APA

Nawafleh, H., Zeinelabdin, N., Greene, M. K., Krishnan, A., Ho, L., Genead, M., Kunimoto, D., Scott, C. J., Tolentino, M., & Chouaib, S. (2024). Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity. Pharmaceuticals, 17(11), 1443. https://doi.org/10.3390/ph17111443

Vancouver

Nawafleh H, Zeinelabdin N, Greene MK, Krishnan A, Ho L, Genead M, et al. Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity. Pharmaceuticals. 2024;17(11):1443. doi:10.3390/ph17111443

BibTeX
@article{Nawafleh2024,
  author = {Nawafleh, Husam and Zeinelabdin, Nagwa and Greene, Michelle K and Krishnan, Anitha and Ho, Linus and Genead, Mohamed and Kunimoto, Derek and Scott, Christopher J and Tolentino, Michael and Chouaib, Salem},
  title = {Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {11},
  pages = {1443},
  doi = {10.3390/ph17111443}
}
Kostenlos starten →